Description
PRESCRIPTION MEDICATION IS NEEDED FOR IMMEDIATE PATIENT CARE AT THE NASHVILLE VA MEDICAL CENTER IN NASHVILLE, TENNESSEE. THE MEDICATION IS UVADEX STERILE SOLUTION.
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-07-13+$25,302= $25,302
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-07-13 | +$25,302 | $25,302 | PRESCRIPTION MEDICATION IS NEEDED FOR IMMEDIATE PATIENT CARE AT THE NASHVILLE VA MEDICAL CENTER IN NASHVILLE,… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KGLHB9TM34M5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926N0652 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $32,456 | FY2026 |
| 36C24926N0519 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $117,000 | FY2026 |
| 36C24925N0733 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $111,708 | FY2025 |
| 36C24925N0683 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $32,456 | FY2025 |
| 36C24925N0574 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $111,708 | FY2025 |
| 36C24925N0269 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $106,524 | FY2025 |
Other recipients under 6505 from 626-NASHVILLE (00626) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24918F2128 | ABBVIE US LLC | 626-NASHVILLE (00626) | $8,874 | FY2018 |
| 36C24918N1818 | NEUROCRINE BIOSCIENCES, INC. | 626-NASHVILLE (00626) | $4,660 | FY2018 |
| 36C24918N1672 | ABBVIE US LLC | 626-NASHVILLE (00626) | $4,363 | FY2018 |
| 36C24918N1434 | GRIFOLS THERAPEUTICS LLC | 626-NASHVILLE (00626) | $12,807 | FY2018 |
| 36C24918N1404 | ABBVIE US LLC | 626-NASHVILLE (00626) | $8,874 | FY2018 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24917P4068_3600_-NONE-_-NONE- · retrieved 2026-09-26.